hydralazine has been researched along with Glomerulonephritis in 63 studies
Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.
Glomerulonephritis: Inflammation of the renal glomeruli (KIDNEY GLOMERULUS) that can be classified by the type of glomerular injuries including antibody deposition, complement activation, cellular proliferation, and glomerulosclerosis. These structural and functional abnormalities usually lead to HEMATURIA; PROTEINURIA; HYPERTENSION; and RENAL INSUFFICIENCY.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hydralazine, a widely used therapy for hypertension and heart failure, can elicit autoimmune disease, including anti-neutrophil cytoplasmic antibody associated glomerulonephritis (ANCA-GN)." | 8.02 | Anti-neutrophil cytoplasmic antibody associated glomerulonephritis complicating treatment with hydralazine. ( Appel, GB; Batal, I; Bomback, AS; Canetta, PA; D'Agati, VD; Kudose, S; Markowitz, GS; Radhakrishnan, J; Santoriello, D; Stokes, MB, 2021) |
| "Hydralazine is a common vasodilator which has been used for the treatment of hypertension and heart failure." | 7.96 | Hydralazine-induced antineutrophil cytoplasmic antibody-associated vasculitis with pulmonary-renal syndrome: a case report. ( Al-Abdouh, A; Bekele, A; Garcia, P; Seid, H; Siyal, AM, 2020) |
| "We report a rare case of Hydralazine-induced ANCA associated glomerulonephritis with alveolar hemorrhage in the setting of acute Clostridium Difficile Infection." | 7.83 | Hydralazine-Induced ANCA Vasculitis in the Setting of Acute Clostridium Difficile Infection. ( Cucu, DF; El Meligy, A; Rasla, S, 2016) |
| "Hydralazine is a medication that has been used to manage hypertension and heart failure." | 7.80 | Hydralazine associated pauci-immune glomerulonephritis. ( Baiswar, S; Suneja, M; Vogelgesang, SA, 2014) |
| "We report a case of hydralazine-induced alveolar hemorrhage and anti-neutrophil cytoplasmic antibody (ANCA)-positive pauci-immune glomerulonephritis, with serum anti-histone antibodies present, features not previously described in the literature with this drug." | 7.75 | Hydralazine-induced ANCA-positive pauci-immune glomerulonephritis: a case report and literature review. ( Dobre, M; Negrea, L; Wish, J, 2009) |
| "We have undertaken an investigation retrospectively of 21 patients with positive antinuclear antibodies, who had been on hydralazine treatment and developed a glomerulonephritis." | 7.69 | Occurrence of autoantibodies directed against myeloperoxidase and elastase in patients treated with hydralazine and presenting with glomerulonephritis. ( Nässberger, L; Thysell, H; Torffvit, O, 1994) |
| "Autoantibodies against myeloperoxidase and elastase were found in a study of nine patients who had developed glomerulonephritis after treatment with hydralazine, but not in patients who were treated with hydralazine without side-effects." | 7.68 | Antibodies to neutrophil granulocyte myeloperoxidase and elastase: autoimmune responses in glomerulonephritis due to hydralazine treatment. ( Björck, S; Johansson, AC; Nässberger, L; Sjöholm, AG, 1991) |
| " Immune complex glomerulonephritis has been demonstrated in a few cases of SLE following procainamide or anticonvulsant therapy but has not been documented in association with hydralazine-induced SLE despite the recognition of this syndrome 30 years ago." | 7.67 | Immune complex glomerulonephritis in hydralazine-induced SLE. ( Harrington, JT; Levey, AS; Pinn, VW; Shapiro, KS, 1984) |
| "Nine patients (6 men, 3 women) with rapidly progressive glomerulonephritis developing during hydralazine therapy were seen." | 7.67 | Hydralazine-associated glomerulonephritis. ( Björck, S; Svalander, C; Westberg, G, 1985) |
| "Hydralazine-induced lupus was first described in 1953." | 5.48 | Hydralazine-associated antineutrophil cytoplasmic antibody vasculitis with pulmonary-renal syndrome. ( Aeddula, NR; Ansari, A; Juran, PJ; Pathireddy, S, 2018) |
| "Hydralazine, an arterial vasodilator, is a widely used medication for the management of hypertension and heart failure, especially for patients who cannot tolerate the use of ACEIs or ARBs." | 5.12 | Hydralazine-Induced ANCA Associated Vasculitis (AAV) Presenting with Pulmonary-Renal Syndrome (PRS): A Case Report with Literature Review. ( Al-Sadawi, M; Battisha, A; Doughem, K; Konduru, L; Madoukh, B; Shaikh, S; Sheikh, O, 2021) |
| " We present a patient with hydralazine-induced antineutrophil cytoplasmic antibodies-positive vasculitis with a pulmonary-renal syndrome manifesting as pauci-immune glomerulonephritis and alveolar haemorrhage." | 4.31 | Diagnostic dilemma: drug-induced vasculitis versus systemic vasculitis. ( Acharya, I; Arend, LJ; Smith, LW; Weisman, DS, 2023) |
| "Hydralazine, a widely used therapy for hypertension and heart failure, can elicit autoimmune disease, including anti-neutrophil cytoplasmic antibody associated glomerulonephritis (ANCA-GN)." | 4.02 | Anti-neutrophil cytoplasmic antibody associated glomerulonephritis complicating treatment with hydralazine. ( Appel, GB; Batal, I; Bomback, AS; Canetta, PA; D'Agati, VD; Kudose, S; Markowitz, GS; Radhakrishnan, J; Santoriello, D; Stokes, MB, 2021) |
| "Hydralazine is a common vasodilator which has been used for the treatment of hypertension and heart failure." | 3.96 | Hydralazine-induced antineutrophil cytoplasmic antibody-associated vasculitis with pulmonary-renal syndrome: a case report. ( Al-Abdouh, A; Bekele, A; Garcia, P; Seid, H; Siyal, AM, 2020) |
| "We report a rare case of Hydralazine-induced ANCA associated glomerulonephritis with alveolar hemorrhage in the setting of acute Clostridium Difficile Infection." | 3.83 | Hydralazine-Induced ANCA Vasculitis in the Setting of Acute Clostridium Difficile Infection. ( Cucu, DF; El Meligy, A; Rasla, S, 2016) |
| "Hydralazine is a medication that has been used to manage hypertension and heart failure." | 3.80 | Hydralazine associated pauci-immune glomerulonephritis. ( Baiswar, S; Suneja, M; Vogelgesang, SA, 2014) |
| "We report a case of hydralazine-induced alveolar hemorrhage and anti-neutrophil cytoplasmic antibody (ANCA)-positive pauci-immune glomerulonephritis, with serum anti-histone antibodies present, features not previously described in the literature with this drug." | 3.75 | Hydralazine-induced ANCA-positive pauci-immune glomerulonephritis: a case report and literature review. ( Dobre, M; Negrea, L; Wish, J, 2009) |
| " After 4 weeks of DOCA-salt hypertension, rats were either killed (n = 6), or treated with a non-hypotensive dose of spironolactone (n = 7) or triple therapy (hydrochlorothiazide, reserpine and hydralazine, n = 8) to normalize blood pressure or with vehicle (n = 19) for two further weeks." | 3.74 | Blood pressure versus direct mineralocorticoid effects on kidney inflammation and fibrosis in DOCA-salt hypertension. ( Cordasic, N; Hartner, A; Hilgers, KF; Klanke, B; Schmieder, RE; Veelken, R, 2008) |
| "We have undertaken an investigation retrospectively of 21 patients with positive antinuclear antibodies, who had been on hydralazine treatment and developed a glomerulonephritis." | 3.69 | Occurrence of autoantibodies directed against myeloperoxidase and elastase in patients treated with hydralazine and presenting with glomerulonephritis. ( Nässberger, L; Thysell, H; Torffvit, O, 1994) |
| "Autoantibodies against myeloperoxidase and elastase were found in a study of nine patients who had developed glomerulonephritis after treatment with hydralazine, but not in patients who were treated with hydralazine without side-effects." | 3.68 | Antibodies to neutrophil granulocyte myeloperoxidase and elastase: autoimmune responses in glomerulonephritis due to hydralazine treatment. ( Björck, S; Johansson, AC; Nässberger, L; Sjöholm, AG, 1991) |
| " Immune complex glomerulonephritis has been demonstrated in a few cases of SLE following procainamide or anticonvulsant therapy but has not been documented in association with hydralazine-induced SLE despite the recognition of this syndrome 30 years ago." | 3.67 | Immune complex glomerulonephritis in hydralazine-induced SLE. ( Harrington, JT; Levey, AS; Pinn, VW; Shapiro, KS, 1984) |
| "Chronic administration of nitrendipine (N) prevented the development of serious renal damage in Wistar rats with experimental glomerulonephritis." | 3.67 | Comparison of BAY e 5009 (nitrendipine) with dihydralazine in Wistar rats with experimentally induced nephritis. ( Mohácsi, G; Sonkodi, S, 1988) |
| "Two patients with rapidly progressive glomerulonephritis associated with hydralazine are reported." | 3.67 | Rapidly progressive nephritis in patients taking hydralazine. ( Lockwood, CM; Mason, PD, 1986) |
| "Nine patients (6 men, 3 women) with rapidly progressive glomerulonephritis developing during hydralazine therapy were seen." | 3.67 | Hydralazine-associated glomerulonephritis. ( Björck, S; Svalander, C; Westberg, G, 1985) |
| "Hydralazine-induced lupus was first described in 1953." | 1.48 | Hydralazine-associated antineutrophil cytoplasmic antibody vasculitis with pulmonary-renal syndrome. ( Aeddula, NR; Ansari, A; Juran, PJ; Pathireddy, S, 2018) |
| "Hydralazine is a commonly used drug for treatment of hypertension and is known to cause drug-induced lupus erythematosus." | 1.38 | Hydralazine-induced ANCA vasculitis with pulmonary renal syndrome: a rare clinical presentation. ( Kaw, D; Malhotra, D; Marina, VP, 2012) |
| "Treatment with captopril also reduced the development of glomerular sclerosis." | 1.29 | Effects of captopril and hydralazine on progression of adriamycin nephropathy in spontaneously hypertensive rats. ( Bogdanovic, G; Djukanovic, L; Jovanovic, D; Kartaljevic, G; Starcevic, A; Susic, D; Varagic, J, 1994) |
| "Six women with hypertension are described who developed an immune complex glomerulonephritis after taking 50-300 mg hydralazine daily for 6 months to 7 years." | 1.27 | Hydralazine and lupus nephritis. ( Dowling, JP; Ihle, BU; Kincaid-Smith, P; Whitworth, JA, 1984) |
| "Propranolol was given to 10 hypertensive patients with CGN and hypotensive effect on renal function was observed." | 1.25 | Therapy and prognosis of hypertension in chronic nephritis. ( Kajiwara, N, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 42 (66.67) | 18.7374 |
| 1990's | 7 (11.11) | 18.2507 |
| 2000's | 2 (3.17) | 29.6817 |
| 2010's | 7 (11.11) | 24.3611 |
| 2020's | 5 (7.94) | 2.80 |
| Authors | Studies |
|---|---|
| Acharya, I | 1 |
| Weisman, DS | 1 |
| Smith, LW | 1 |
| Arend, LJ | 1 |
| Al-Abdouh, A | 1 |
| Siyal, AM | 1 |
| Seid, H | 1 |
| Bekele, A | 1 |
| Garcia, P | 1 |
| Doughem, K | 1 |
| Battisha, A | 1 |
| Sheikh, O | 1 |
| Konduru, L | 1 |
| Madoukh, B | 1 |
| Al-Sadawi, M | 1 |
| Shaikh, S | 1 |
| Santoriello, D | 1 |
| Bomback, AS | 2 |
| Kudose, S | 1 |
| Batal, I | 1 |
| Stokes, MB | 1 |
| Canetta, PA | 1 |
| Radhakrishnan, J | 1 |
| Appel, GB | 1 |
| D'Agati, VD | 1 |
| Markowitz, GS | 1 |
| Tu, W | 1 |
| Fayman, B | 1 |
| Ward, SC | 1 |
| Mamoon, Y | 1 |
| Bandagi, SS | 1 |
| Aeddula, NR | 1 |
| Pathireddy, S | 1 |
| Ansari, A | 1 |
| Juran, PJ | 1 |
| Suneja, M | 1 |
| Baiswar, S | 1 |
| Vogelgesang, SA | 1 |
| Rasla, S | 1 |
| El Meligy, A | 1 |
| Cucu, DF | 1 |
| Klanke, B | 1 |
| Cordasic, N | 1 |
| Hartner, A | 1 |
| Schmieder, RE | 1 |
| Veelken, R | 1 |
| Hilgers, KF | 1 |
| Dobre, M | 1 |
| Wish, J | 1 |
| Negrea, L | 1 |
| Kalra, A | 1 |
| Yokogawa, N | 1 |
| Raja, H | 1 |
| Palaniswamy, C | 1 |
| Desai, P | 1 |
| Zanotti-Cavazzoni, SL | 1 |
| Rajaram, SS | 1 |
| Leelahavanichkul, A | 1 |
| Yan, Q | 1 |
| Hu, X | 1 |
| Eisner, C | 1 |
| Huang, Y | 1 |
| Chen, R | 1 |
| Mizel, D | 1 |
| Zhou, H | 1 |
| Wright, EC | 1 |
| Kopp, JB | 1 |
| Schnermann, J | 1 |
| Yuen, PS | 1 |
| Star, RA | 1 |
| Marina, VP | 1 |
| Malhotra, D | 1 |
| Kaw, D | 1 |
| FIASCHI, E | 1 |
| GRASSI, B | 1 |
| ANDRES, G | 1 |
| DYK, T | 1 |
| VILLARROEL, L | 1 |
| CID, L | 1 |
| HERNANDEZ, R | 1 |
| OYARCE, P | 1 |
| JAMES, JA | 1 |
| FINK, CW | 1 |
| KROGSGAARD, AR | 1 |
| BENDERLY, A | 1 |
| WEAVER, KH | 1 |
| DODGE, WF | 1 |
| TRAVIS, LB | 1 |
| FARIDAY, EE | 1 |
| DAVID, JK | 1 |
| MCQUIGGAN, MC | 1 |
| OLIVER, WJ | 1 |
| LITTLER, ER | 1 |
| CERNY, JC | 1 |
| MEIRING, PD | 1 |
| SMITH, FG | 1 |
| LITMAN, N | 1 |
| LATTA, H | 1 |
| REUBI, F | 1 |
| GOSSWEILER, N | 1 |
| GUERTLER, R | 1 |
| HUBER, A | 1 |
| SCHMID, M | 1 |
| Thiele, KG | 1 |
| Muehrcke, RC | 1 |
| Berning, H | 1 |
| Björck, S | 4 |
| Westberg, G | 3 |
| Svalander, C | 3 |
| Mulec, H | 1 |
| Kincaid-Smith, P | 2 |
| Whitworth, JA | 2 |
| Shapiro, KS | 1 |
| Pinn, VW | 1 |
| Harrington, JT | 1 |
| Levey, AS | 1 |
| Ihle, BU | 1 |
| Dowling, JP | 1 |
| Naparstek, Y | 1 |
| Kopolovic, J | 1 |
| Tur-Kaspa, R | 1 |
| Rubinger, D | 1 |
| Torffvit, O | 1 |
| Thysell, H | 1 |
| Nässberger, L | 3 |
| Djukanovic, L | 1 |
| Susic, D | 1 |
| Jovanovic, D | 2 |
| Varagic, J | 1 |
| Starcevic, A | 1 |
| Kartaljevic, G | 1 |
| Bogdanovic, G | 1 |
| Cambridge, G | 1 |
| Wallace, H | 1 |
| Bernstein, RM | 1 |
| Leaker, B | 1 |
| Yamamoto, M | 1 |
| Fukui, M | 1 |
| Shou, I | 1 |
| Wang, LN | 1 |
| Sekizuka, K | 1 |
| Suzuki, S | 1 |
| Shirato, I | 1 |
| Tomino, Y | 1 |
| Börner, H | 1 |
| Teichmann, G | 1 |
| Kajiwara, N | 1 |
| Johansson, AC | 1 |
| Sjöholm, AG | 1 |
| Thompson, CH | 1 |
| Kalowski, S | 1 |
| Mohácsi, G | 1 |
| Sonkodi, S | 1 |
| Yoshida, Y | 1 |
| Kawamura, T | 1 |
| Ikoma, M | 1 |
| Fogo, A | 1 |
| Ichikawa, I | 1 |
| Feld, LG | 1 |
| Noble, B | 1 |
| Springate, JE | 1 |
| Feldman, MJ | 1 |
| Van Liew, JB | 1 |
| Raij, L | 1 |
| Chiou, XC | 1 |
| Owens, R | 1 |
| Wrigley, B | 1 |
| Widgren, B | 1 |
| Berglund, G | 1 |
| Andersson, OK | 2 |
| Mason, PD | 1 |
| Lockwood, CM | 1 |
| Widgren, BR | 1 |
| Berglund, GL | 1 |
| Abella, R | 1 |
| Blondeel, NJ | 1 |
| Roguska, J | 1 |
| Walker, C | 1 |
| Simon, NM | 1 |
| Del Greco, F | 1 |
| Rorive, G | 1 |
| Loggie, JM | 1 |
| Moser, M | 1 |
| Vaidya, RA | 1 |
| Vaidya, AB | 1 |
| Van Woert, MH | 1 |
| Kase, NG | 1 |
| Mattern, WD | 1 |
| Sommers, SC | 1 |
| Kassirer, JP | 1 |
| Retan, JW | 1 |
| Dillon, HC | 1 |
| Vertes, V | 1 |
| Cangiano, JL | 1 |
| Berman, LB | 1 |
| Gould, A | 1 |
| Hutchings, RH | 1 |
| Hickman, R | 1 |
| Scribner, BH | 1 |
4 reviews available for hydralazine and Glomerulonephritis
| Article | Year |
|---|---|
Hydralazine-Induced ANCA Associated Vasculitis (AAV) Presenting with Pulmonary-Renal Syndrome (PRS): A Case Report with Literature Review.
Topics: Aged; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Female; Glomerulonephritis; Heart | 2021 |
ACUTE GLOMERULONEPHRITIS: REVIEW OF RECENT ADVANCES.
Topics: Antibodies; Child; Drug Therapy; Glomerulonephritis; Hemodynamics; Humans; Hydralazine; Pathology; P | 1964 |
Hypertension in children and adolescents. II. Drug therapy.
Topics: Age Factors; Antihypertensive Agents; Blood Pressure Determination; Child; Chlorothiazide; Chronic D | 1969 |
Treatment of "hypertensive encephalopathy" (accelerated hypertension). II.
Topics: Antihypertensive Agents; Diazoxide; Glomerulonephritis; Guanethidine; Humans; Hydralazine; Hypertens | 1969 |
1 trial available for hydralazine and Glomerulonephritis
| Article | Year |
|---|---|
Effects of treatment on morbidity in hypertension. 3. Influence of age, diastolic pressure, and prior cardiovascular disease; further analysis of side effects.
Topics: Adult; Age Factors; Aged; Aneurysm; Atrial Fibrillation; Blood Glucose; Blood Pressure; Cerebrovascu | 1972 |
58 other studies available for hydralazine and Glomerulonephritis
| Article | Year |
|---|---|
Diagnostic dilemma: drug-induced vasculitis versus systemic vasculitis.
Topics: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antibodies, Antineutrophil Cytoplasmic; | 2023 |
Hydralazine-induced antineutrophil cytoplasmic antibody-associated vasculitis with pulmonary-renal syndrome: a case report.
Topics: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Female; Glomerulonephritis; Hemorrhage; | 2020 |
Anti-neutrophil cytoplasmic antibody associated glomerulonephritis complicating treatment with hydralazine.
Topics: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antibodies, Antineutrophil Cytoplasmic; | 2021 |
Hydralazine-Induced Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Asymptomatic and Renal-Restricted Presentation.
Topics: Aged; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antibodies, Antineutrophil Cytopla | 2021 |
Hydralazine-associated antineutrophil cytoplasmic antibody vasculitis with pulmonary-renal syndrome.
Topics: Aged; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Biopsy; Blood Protein Electrophore | 2018 |
Hydralazine associated pauci-immune glomerulonephritis.
Topics: Aged; Aged, 80 and over; Amlodipine; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Ant | 2014 |
Hydralazine-Induced ANCA Vasculitis in the Setting of Acute Clostridium Difficile Infection.
Topics: Adrenal Cortex Hormones; Aged; Antibodies, Antineutrophil Cytoplasmic; Antihypertensive Agents; Clos | 2016 |
An Elderly Man with Fatigue, Dyspnea, and Kidney Failure.
Topics: Aged; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antibodies, Antineutrophil Cytopla | 2017 |
Blood pressure versus direct mineralocorticoid effects on kidney inflammation and fibrosis in DOCA-salt hypertension.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Desoxycorticosterone; Disease Models, Animal; Dise | 2008 |
Hydralazine-induced ANCA-positive pauci-immune glomerulonephritis: a case report and literature review.
Topics: Antibodies, Antineutrophil Cytoplasmic; Antihypertensive Agents; Female; Glomerulonephritis; Humans; | 2009 |
Hydralazine-induced pulmonary-renal syndrome: a case report.
Topics: Aged; Female; Glomerulonephritis; Glucocorticoids; Hemorrhage; Humans; Hydralazine; Immunosuppressiv | 2012 |
Angiotensin II overcomes strain-dependent resistance of rapid CKD progression in a new remnant kidney mouse model.
Topics: Albuminuria; Anemia; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertens | 2010 |
Hydralazine-induced ANCA vasculitis with pulmonary renal syndrome: a rare clinical presentation.
Topics: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antihypertensive Agents; Glomerulonephri | 2012 |
[Hydrazinophthalazine in the treatment of glomerulonephritis caused by focal sepsis].
Topics: Glomerulonephritis; Hydralazine; Pharyngeal Diseases; Pharynx; Sepsis; Sympatholytics | 1955 |
[Combined serpasil, apresoline and verlloid therapy of hypertensive form of glomerulonephritis].
Topics: Antihypertensive Agents; Glomerulonephritis; Humans; Hydralazine; Hypertension; Reserpine | 1957 |
[Apresoline in the treatment of hypertension caused by glomerulonephritis in children].
Topics: Glomerulonephritis; Humans; Hydralazine; Hypertension | 1957 |
ACUTE GLOMERULONEPHRITIS.
Topics: Blood Chemical Analysis; Child; Convalescence; Edema; Electrocardiography; Erythromycin; Glomerulone | 1964 |
[MEDICAL TREATMENT OF HYPERTENSIVE CRISES].
Topics: Diuretics; Female; Ganglionic Blockers; Glomerulonephritis; Hexamethonium Compounds; Humans; Hydrala | 1964 |
[TREATMENT OF HYPERTENSION DUE TO ACUTE GLOMERULONEPHRITIS WITH PARENTERAL RESERPINE AND HYDRALAZINE].
Topics: Glomerulonephritis; Hydralazine; Hypertension; Hypertension, Renal; Infusions, Parenteral; Kidney; R | 1964 |
THE HEART AND ACUTE GLOMERULONEPHRITIS.
Topics: Child; Diet, Sodium-Restricted; Digitalis Glycosides; Drug Therapy; Glomerulonephritis; Heart Diseas | 1964 |
ACUTE GLOMERULONEPHRITIS IN CHILDREN. A REVIEW OF THIRTY-EIGHT CASES.
Topics: Acute Disease; Child; Drug Therapy; Glomerulonephritis; Hydralazine; Infant; Reserpine; Urine | 1964 |
HEMOLYTIC UREMIC SYNDROME.
Topics: Acute Kidney Injury; Anemia, Hemolytic; Child; Diagnosis; Dialysis; Diarrhea; Drug Therapy; Glomerul | 1965 |
EXPERIENCES WITH THE LONG-TERM USE OF METHYLDOPA ("ALDOMET") IN HYPERTENSION.
Topics: Benzothiadiazines; Blood Pressure Determination; Depression; Drug Therapy; Drug Tolerance; Glomerulo | 1965 |
LUPUS GLOMERULONEPHRITIS. THE EFFECT OF LARGE DOSES OF CORTICOSTEROIDS ON RENAL FUNCTION AND RENAL LESIONS IN TWO CHILDREN.
Topics: Adolescent; Adrenal Cortex Hormones; Cortisone; Drug Therapy; Glomerulonephritis; Guanethidine; Hydr | 1965 |
[THE DETERMINATION OF THE RENAL BLOOD FLOW BY MEANS OF A METHOD OF DILUTION].
Topics: Anuria; Blood Flow Velocity; Dye Dilution Technique; Glomerulonephritis; Humans; Hydralazine; Kidney | 1964 |
[Kidney diseases caused by drugs].
Topics: Acute Kidney Injury; Adult; Anemia; Arthritis, Rheumatoid; Dextrans; Drug-Related Side Effects and A | 1967 |
Rapidly progressive glomerulonephritis after hydralazine.
Topics: Glomerulonephritis; Humans; Hydralazine; Hypertension | 1983 |
Hydralazine-associated glomerulonephritis.
Topics: Adult; Aged; Female; Glomerulonephritis; Humans; Hydralazine; Middle Aged | 1983 |
Immune complex glomerulonephritis in hydralazine-induced SLE.
Topics: Aged; Arteritis; Female; Glomerulonephritis; Humans; Hydralazine; Immune Complex Diseases; Kidney Di | 1984 |
Hydralazine and lupus nephritis.
Topics: Adult; Aged; Female; Glomerulonephritis; Humans; Hydralazine; Hypertension; Immune Complex Diseases; | 1984 |
Renal failure, dyspnea and anemia in a 57 year old woman. Clinicopathologic conference.
Topics: Anemia; Diagnosis, Differential; Dyspnea; Female; Glomerulonephritis; Humans; Hydralazine; Hypertens | 1981 |
[Glomerulonephritis - hydralazine].
Topics: Glomerulonephritis; Humans; Hydralazine | 1984 |
Focal glomerulonephritis in the course of hydralazine-induced lupus syndrome.
Topics: Biopsy; Glomerulonephritis; Humans; Hydralazine; Hypertension; Kidney; Lupus Erythematosus, Systemic | 1984 |
Occurrence of autoantibodies directed against myeloperoxidase and elastase in patients treated with hydralazine and presenting with glomerulonephritis.
Topics: Adult; Antibodies, Antinuclear; Antibody Specificity; Autoantibodies; Fluorescent Antibody Technique | 1994 |
Effects of captopril and hydralazine on progression of adriamycin nephropathy in spontaneously hypertensive rats.
Topics: Animals; Blood Pressure; Body Weight; Captopril; Doxorubicin; Female; Glomerulonephritis; Hematocrit | 1994 |
Autoantibodies to myeloperoxidase in idiopathic and drug-induced systemic lupus erythematosus and vasculitis.
Topics: Adolescent; Adult; Aged; Antibodies, Antineutrophil Cytoplasmic; Antibody Specificity; Autoantibodie | 1994 |
Granulocyte autoantibodies--markers for drug-induced autoimmune adverse effects.
Topics: Antibodies, Antineutrophil Cytoplasmic; Autoantibodies; Autoimmune Diseases; Biomarkers; Glomerulone | 1993 |
Effects of treatment with angiotensin-converting enzyme inhibitor (ACEI) or angiotensin II receptor antagonist (AIIRA) on renal function and glomerular injury in subtotal nephrectomized rats.
Topics: Albuminuria; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Bl | 1997 |
[Hemodynamic parameters and plasma-renin activity following intravenous dihydralazine administration--a contribution to the regulation of renin].
Topics: Adolescent; Adult; Arterial Occlusive Diseases; Dihydralazine; Female; Glomerulonephritis; Humans; H | 1978 |
Therapy and prognosis of hypertension in chronic nephritis.
Topics: Adult; Aldosterone; Angiotensin II; Blood Volume; Catecholamines; Chronic Disease; Creatinine; Extra | 1975 |
Antibodies to neutrophil granulocyte myeloperoxidase and elastase: autoimmune responses in glomerulonephritis due to hydralazine treatment.
Topics: Autoantibodies; Cytoplasm; Enzyme-Linked Immunosorbent Assay; Female; Fluorescent Antibody Technique | 1991 |
Anti-glomerular basement membrane nephritis due to hydralazine.
Topics: Autoantibodies; Basement Membrane; Glomerulonephritis; Humans; Hydralazine; Immunoglobulin G; Kidney | 1991 |
Comparison of BAY e 5009 (nitrendipine) with dihydralazine in Wistar rats with experimentally induced nephritis.
Topics: Animals; Antibodies; Basement Membrane; Blood Pressure; Dihydralazine; Glomerulonephritis; Hydralazi | 1988 |
Effects of antihypertensive drugs on glomerular morphology.
Topics: Animals; Antihypertensive Agents; Enalapril; Glomerulonephritis; Glomerulosclerosis, Focal Segmental | 1989 |
Hydralazine-induced glomerulonephritis.
Topics: Diagnosis, Differential; Female; Glomerulonephritis; Humans; Hydralazine; Male | 1985 |
Dietary protein restriction and renal injury in the spontaneously hypertensive rat.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Chlorothiazide; Dietary Proteins; Glo | 1989 |
Therapeutic implications of hypertension-induced glomerular injury. Comparison of enalapril and a combination of hydralazine, reserpine, and hydrochlorothiazide in an experimental model.
Topics: Animals; Enalapril; Glomerular Filtration Rate; Glomerular Mesangium; Glomerulonephritis; Glomerulos | 1985 |
Side-effects in long-term treatment with hydralazine.
Topics: Aged; Female; Glomerulonephritis; Humans; Hydralazine; Hypertension; Lupus Erythematosus, Systemic; | 1986 |
Rapidly progressive nephritis in patients taking hydralazine.
Topics: Female; Glomerulonephritis; Humans; Hydralazine; Male; Middle Aged; Time Factors | 1986 |
[Adverse effects of prolonged treatment with hydralazine--a retrospective study].
Topics: Aged; Female; Glomerulonephritis; Humans; Hydralazine; Kidney; Lupus Erythematosus, Systemic; Male; | 1986 |
Hydralazine-associated glomerulonephritis.
Topics: Antibodies, Antinuclear; Female; Fluorescent Antibody Technique; Glomerulonephritis; Humans; Hydrala | 1985 |
Periodic dialysis in terminal uremia.
Topics: Adolescent; Adult; Anemia; Arthritis; Child; Female; Gastrointestinal Hemorrhage; Glaucoma; Glomerul | 1967 |
[Hypertension of renal origin].
Topics: Clonidine; Diet, Sodium-Restricted; Glomerulonephritis; Humans; Hydralazine; Hypertension, Renal; Ki | 1973 |
Galactorrhea and Parkinson-like syndrome: an adverse effect of alpha-methyldopa.
Topics: Adolescent; Amenorrhea; Female; Glomerulonephritis; Humans; Hydralazine; Hypertension; Kidney Transp | 1970 |
Oliguric acute renal failure in malignant hypertension.
Topics: Acute Kidney Injury; Adult; Anuria; Blood Urea Nitrogen; Diagnosis, Differential; Female; Glomerulon | 1972 |
Furosemide in the treatment of acute post-streptococcal glomerulonephritis.
Topics: Bicarbonates; Blood Pressure Determination; Blood Urea Nitrogen; Child; Chlorides; Creatinine; Edema | 1969 |
Hypertension in end-stage renal disease.
Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Black People; Blood Pressure; Body Weight; Chronic | 1969 |
Chronic hemodialysis in a pre-adolescent.
Topics: Adolescent; Child; Diet, Sodium-Restricted; Female; Glomerulonephritis; Hematocrit; Humans; Hydralaz | 1966 |